z.mensa
Submits third-party assay reports on material purchased directly. Based in Catania.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.24%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043430 | L-Glutathione (reduced) | WXT | WXT-2605-B3833 | Medutest | 2026-Q3 | 97.82 | 6.81 | 106.0 | Buyer-sourced | 0 | FAIL |
| AX-2026-042460 | Retatrutide | Homopeptide | HOMO-2512-D4932 | Medutest | 2026-Q2 | 98.40 | 3.82 | 101.4 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043088 | Semaglutide | KP | KP-2511-J5553 | PeptideMeter | 2026-Q2 | 99.77 | 8.11 | 98.4 | Buyer-sourced | 0 | FAIL |
| AX-2026-042285 | Epitalon | TFC | TFC-2511-E9934 | Janoshik | 2026-Q1 | 99.93 | 6.31 | 104.1 | Buyer-sourced | 1 | FAIL |
| AX-2025-018799 | Semaglutide | FGP | FGP-2506-J7851 | Kestrel | 2025-Q4 | 99.93 | 4.76 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020859 | TB-500 | CPC | CPC-2411-X1899 | Janoshik | 2025-Q2 | 99.58 | 2.32 | 95.7 | Buyer-sourced | 3 | FAIL |
| AX-2025-019524 | GHRP-6 | JEEP | JEEP-2503-B8635 | Janoshik | 2025-Q2 | 99.35 | 5.03 | 94.5 | Buyer-sourced | 0 | PASS |
| AX-2025-020050 | Retatrutide | SWB | SWB-2503-P7565 | Janoshik | 2025-Q2 | 98.17 | 4.97 | 99.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004505 | Retatrutide | HYB | HYB-2407-W6594 | Medutest | 2024-Q3 | 98.79 | 5.05 | 90.3 | Buyer-sourced | 0 | PASS |
| AX-2024-004678 | Semaglutide | Homopeptide | HOMO-2401-R3356 | Medutest | 2024-Q2 | 99.13 | 2.32 | — | Buyer-sourced | 0 | PASS |